I believe that the NRC has appropriately responded to Fukushima with several new requirements addressing Tier 1 issues.

NRC's gold standard for nuclear safety oversight is essential, absolutely, and something that I strongly support.

Budgets are, indeed, a statement of policy. The NRC budget for fiscal year 2015 shows an increase in resources and staffing despite a shrinking fleet of reactors.

We know that nuclear energy is an indispensable source of clean, reliable, affordable power; however, economic headwinds are challenging the viability of some plants, with four closing last year and more to follow.

The self-proclaimed most transparent administration in history has repeatedly dodged our simple questions about the health care law.

At this subcommittee, our investigations are about getting the facts--a quest for transparency.

The American public does deserve better.

I want to commend particularly you, Chairman Pitts and Ranking Member Pallone, for your collaboration on today's hearing.

We are here today to explore the opportunities 21st century technology presents to improve the lives of patients and advance our health care system.

We have a great opportunity to come together to expand the use of telehealth in this country.

This will be a priority of the Committee on Energy and Commerce over the next couple of years.

I joined with my Republican colleague, Representative Devin Nunes, to introduce the Telemedicine for Medicare or TELE-MED Act.

We must ensure program integrity is preserved and utilization costs do not rise.

Our work to reform TSCA indeed has come a long, long way.

Our work to reform TSCA has come a long way.

I particularly want to thank Mr. Shimkus for his leadership on this issue and efforts to find bipartisan common ground.

We appreciate the technical assistance EPA has provided thus far.

This law has not been updated in nearly 40 years.

We want to reinforce public confidence in the safety of chemical substances contained in a wide variety of products that we encounter every single day.

I am a firm believer that transparency does breed accountability.

We have a collective responsibility as the FDA's authorizing committee to ensure the Agency is implementing the law, and all laws, in a fair, consistent and transparent manner.

This bill establishes a collaborative and coordinated approach to the prescription drug abuse crisis that certainly is plaguing our local communities across the country.

I want to commend my colleagues for working together to develop these legislative solutions.

It is long overdue that we find a solution to the current backlog of sunscreen ingredients pending at the FDA, and this bill does it.

I want to commend Chairman Murphy's efforts, and those of the Ranking Member of the Oversight and Investigations Subcommittee, Diana DeGette, to ensure a bipartisan focus on these vital issues.